Unlocking the Potential of the Prebiotics Human Milk Oligosaccharide (HMO) and Inulin: A Comprehensive Guide

Safety and Tolerance in Diverse Populations

A systematic review of clinical trials involving the supplementation of manufactured HMOs reported that these compounds are safe and well-tolerated across different populations, including infants, children, and adults. The trials consistently noted positive shifts in health outcomes similar to those observed in breastfed infants, such as improved stool characteristics and gut microbiome composition [2].

Impact on Gut Health and Immune Function

Research has also highlighted the role of HMOs in promoting gut health and immune function beyond infancy. For instance, studies have indicated potential benefits of HMO supplementation in managing conditions like Irritable Bowel Syndrome (IBS), where HMOs helped in altering the gut microbiota and reducing symptoms [4]. Additionally, HMOs have shown promise in protecting against viral infections by mimicking viral receptors and enhancing immune responses [4].

Innovations in Infant Nutrition

The addition of HMOs to infant formulas is considered one of the most significant recent innovations in infant nutrition. This approach aims to narrow the gap between the benefits of breast milk and formula, providing non-breastfed infants with similar advantages in terms of digestive health, immunity, and cognitive development [6].

Expanding Research and Potential Therapeutic Roles

The ongoing research into HMOs is not only enhancing our understanding of their roles in infant nutrition but also exploring their potential therapeutic applications in adult health. This includes their use in dietary supplements and functional foods, where their unique properties may contribute to immune modulation and gut health improvement [5][7].

In conclusion, the body of clinical evidence supports the significant health benefits of HMOs, underscoring their importance in both infant and potentially adult nutrition. Further research will continue to elucidate their comprehensive health impacts and therapeutic potentials.

Pros of Prebiotics Human Milk Oligosaccharide (HMO) for Adult Nutrition

The pros of prebiotics Human Milk Oligosaccharides (HMOs) for adults are based on their beneficial effects on the gut microbiota and immune system, as well as their potential role in protecting against enteric infections and other health benefits. Here are the key advantages as highlighted by the provided sources:

• Gut Microbiota Enhancement: HMOs are known to positively influence the establishment of the microbiota not only in infants but also in adults. They can promote the growth of beneficial gut bacteria, which is crucial for maintaining a healthy digestive system [8].
• Protection Against Pathogens: HMOs can impede the attachment of various pathogens and toxins to the epithelial cells of the gastrointestinal tract, which is a prerequisite for infection. By binding to HMOs instead, these pathogens and toxins are removed from the gastrointestinal tract, reducing their pathogenicity and the likelihood of causing disease [8].
• Gut Health and Immune System Benefits: HMOs have been observed to have beneficial effects on gut health and the immune system in adults. This includes potential therapeutic or preventive effects in gut motility disorders, gut pain, and possibly in reducing food allergies [8].
• Short-Chain Fatty Acid Production: A study using the simulator of human intestinal microbial ecosystem (SHIME®) found that supplementation with sialyllactose (a type of HMO) increased the production of short-chain fatty acids (SCFAs) in the culture broth. SCFAs are known to have several health benefits, including serving as an energy source for colonocytes and playing a role in maintaining gut barrier integrity [9].
• Intestinal Barrier Function: The same study also showed that SHIME culture supernatant supplemented with sialyllactose improved the intestinal barrier function in Caco-2 cell monolayers, suggesting that HMOs could help protect against intestinal permeability and related disorders [9].

These findings suggest that HMOs could be a valuable dietary supplement for adults, offering a range of health benefits that extend beyond infancy. However, it is important to note that while these studies provide promising insights, further clinical trials are needed to fully substantiate the effects of HMO supplementation on adult health [2][8][9].

Recent Development of Prebiotics Human Milk Oligosaccharide (HMO) for Adult Nutrition

Recent developments in the application of Human Milk Oligosaccharides (HMOs) for adults primarily focus on their potential therapeutic benefits for gastrointestinal disorders, particularly Irritable Bowel Syndrome (IBS), and their general health-promoting properties.

Therapeutic Potential for Irritable Bowel Syndrome (IBS)

A significant recent development is the exploration of HMOs as a potential therapeutic option for IBS. Research has indicated that HMO supplementation can alter the gut microbiota composition, which in turn may improve symptoms associated with IBS. This includes the stimulation of beneficial bacteria like bifidobacteria, which are known to have positive effects on gut health and function. The promising results from intervention and in vitro trials suggest that further research into the mechanisms of HMOs could confirm their utility in managing IBS symptoms in adults [4].

Cognitive and Immune Support

Human Milk Oligosaccharides (HMOs) are complex carbohydrates found in human breast milk and are known for their significant role in promoting health beyond just nutrition. They are the third most abundant solid component in human milk. Recent studies have expanded our understanding of how HMOs contribute to cognitive and immune support in both infants and potentially adults.

HMOs have been shown to play a crucial role in brain development and cognitive functions. A study highlighted the specific impact of the HMO 2’-fucosyllactose (2’FL) on cognitive development in infants. This study found that higher concentrations of 2’FL in breast milk were associated with better cognitive outcomes in infants at 24 months of age[13]. The mechanism by which HMOs influence brain development is not fully understood but is thought to involve the modulation of gut microbiota, which in turn affects the brain through the gut-brain axis.

HMOs also play a significant role in the development and function of the immune system. They help to establish a healthy gut microbiota, which is crucial for developing a robust immune system. HMOs enhance the growth of beneficial bacteria like bifidobacteria, which are important for gut health and immune function[1][2]. These oligosaccharides can also directly enhance immune functions by acting as anti-adhesives that prevent pathogens from binding to mucosal surfaces, thereby reducing infection risks[1][2].

Potential Benefits in Adults

While most studies focus on infants, the potential benefits of HMOs in adult nutrition are gaining interest. The prebiotic effects of HMOs, such as modulation of the gut microbiota, could potentially enhance immune function and overall gut health in adults as well. However, clinical studies specifically targeting the effects of HMO supplementation in adult diets are limited, and more research is needed to confirm these benefits[1].

Clinical References:

• [1] Dinleyici, Meltem et al. “Functional effects of human milk oligosaccharides (HMOs).” Gut microbes vol. 15,1 (2023): 2186115. doi:10.1080/19490976.2023.2186115. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026937/
• [2] Vandenplas, Yvan et al. “Human Milk Oligosaccharides: 2′-Fucosyllactose (2′-FL) and Lacto-N-Neotetraose (LNnT) in Infant Formula.” Nutrients vol. 10,9 1161. 24 Aug. 2018, doi:10.3390/nu10091161. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6164445/

What are the Prebiotics functional food supplement alternatives to Prebiotics Human Milk Oligosaccharide (HMO)?

Prebiotics Human Milk Oligosaccharide (HMO) is a highly specialized form of prebiotic found naturally in human breast milk, playing a crucial role in the development of the infant gut microbiota. For those seeking functional food supplement alternatives to HMOs, several options are available that can similarly support the growth of beneficial gut bacteria.

• Inulin: This is a very common prebiotic fiber derived from plants such as chicory root, Jerusalem artichoke, and agave. Inulin is soluble and ferments in the colon, promoting the growth of beneficial bacteria.
• Fructooligosaccharides (FOS): Similar to inulin, FOS are extracted from various fruits and vegetables like bananas, onions, and garlic. They are recognized for their capacity to promote the proliferation of bifidobacteria in the gut, which is advantageous for gastrointestinal health.
• Galactooligosaccharides (GOS): Produced from lactose, GOS are structurally more similar to HMOs and can mimic some of the prebiotic effects of HMOs. They are particularly effective in enhancing the growth of bifidobacteria.
• Xylooligosaccharides (XOS): Derived from fibrous materials like bamboo and corn cobs, XOS are known for their selective fermentation by beneficial bacteria, which helps in maintaining a healthy gut flora.
• Resistant Starch: Found in foods like unripe bananas, cooked and cooled potatoes, and whole grains, resistant starch resists digestion in the small intestine and ferments in the large intestine, serving as a food source for beneficial bacteria.
• Polydextrose: A synthetic polymer of glucose, polydextrose acts as a soluble fiber and has prebiotic benefits. It is used in a variety of processed foods to increase their fiber content while also promoting the growth of beneficial intestinal bacteria.

These alternatives can be incorporated into the diet through natural food sources or as dietary supplements, depending on individual health needs and preferences. Each has unique properties and varying degrees of effectiveness in mimicking the specific benefits of HMOs, particularly in terms of fostering a healthy microbiome.

Practical Significance of Prebiotic Inulin

Gut Health Enhancement

Prebiotic inulin is known for its significant role in enhancing gut health by promoting the growth of beneficial gut bacteria. Clinical studies have demonstrated that inulin-type fructans selectively stimulate the growth of Bifidobacteria and Lactobacilli in the colon, which are crucial for maintaining a healthy gut microbiota [11][12]. This selective stimulation helps in improving the overall intestinal environment, which can lead to better digestion and nutrient absorption. Additionally, a study highlighted that inulin supplementation could control inflammation and metabolic endotoxemia in women with type 2 diabetes, indicating its broader impact on gut health and systemic inflammation [14].

Weight Management

Inulin’s role in weight management is supported by its ability to induce a feeling of fullness or satiety, which can naturally lead to a reduction in food intake. A randomized controlled trial found that inulin supplementation could effectively help manage weight and reduce ectopic fat in subjects with prediabetes [13]. This is particularly beneficial in the context of obesity prevention and management. Furthermore, inulin’s low caloric content and its utility as a fat substitute in processed foods enhance its value as a dietary component for weight control.

Blood Sugar Control

The impact of inulin on blood sugar levels is also well-documented. Inulin-type fructans have been shown to reduce postprandial blood glucose and insulin response, which is crucial for people with diabetes [15]. By slowing digestion, inulin helps in moderating blood glucose spikes after meals, thereby aiding in the management of diabetes. This effect was also observed in a study where milk powder supplemented with inulin and resistant dextrin significantly improved glycemic control in elderly patients with type 2 diabetes [16].

Cardiovascular Health

Prebiotic inulin, a dietary fiber, has been studied for its potential benefits in cardiovascular health, primarily through its indirect effects on metabolic factors. While direct clinical evidence specifically linking inulin intake to reduced blood cholesterol is sparse, its role in promoting overall metabolic health is well recognized. Inulin aids in weight management by enhancing feelings of fullness and reducing food intake, which can indirectly mitigate cardiovascular risk factors associated with obesity [17].

Additionally, inulin’s ability to moderate blood glucose levels helps in managing diabetes, a known risk factor for cardiovascular disease. These properties suggest that inulin could play a supportive role in cardiovascular health by addressing key metabolic risk factors, even though more direct evidence from clinical studies would be beneficial to fully establish this relationship.

Origin of Prebiotic Inulin

Introduction to Prebiotic Inulin

Prebiotic inulin is a type of soluble dietary fiber prevalent in a variety of plants, with a high concentration found in chicory root. It belongs to a class of carbohydrates known as fructans, which are polymers of fructose molecules. Inulin serves as a storage carbohydrate in plants and has been recognized for its prebiotic properties, which promote gut health by fostering the growth of beneficial gut bacteria.

Historical Context and Definition

The concept of prebiotics, including substances like inulin, gained prominence in the 1990s. Researchers during this period defined prebiotics as nondigestible food components that beneficially affect the host by selectively stimulating the growth and/or activity of one or a limited number of bacteria in the colon, thus improving host health [18]. Inulin is particularly effective in enhancing the growth of Bifidobacteria and Lactobacilli, making it a valuable prebiotic fiber.

Health Benefits and Clinical Studies

Gut Health and Microbiota

Clinical studies have consistently shown that inulin-type fructans, such as those derived from chicory root, significantly increase the abundance of Bifidobacterium in the gut. A systematic review and meta-analysis confirmed that supplementation with chicory-derived inulin-type fructans at doses ranging from 3–20 g/day effectively promotes Bifidobacterium growth in various age groups, from infants to the elderly [21]. This bifidogenic effect is crucial as Bifidobacteria play a significant role in maintaining gut health and preventing the proliferation of harmful bacteria.

Glucose Regulation and Metabolic Health

Inulin has also been studied for its role in metabolic health, particularly in glucose regulation and lipid metabolism. A multicenter randomized placebo-controlled trial highlighted that physical activity combined with inulin supplementation could enhance improvements in body mass index and metabolic profiles in obese individuals [19].

Another study indicated that inulin could improve insulin sensitivity and lipid metabolism, thereby suggesting its potential in managing diabetes and associated metabolic disorders [18].

Potential in Disease Prevention

Emerging research suggests that inulin may reduce the risk of colon cancer by altering the gut microbiota composition and promoting a healthier intestinal environment [20]. The fermentation of inulin produces short-chain fatty acids, such as butyrate, which have been shown to have anti-inflammatory properties and may inhibit the growth of cancer cells in the colon.

Extraction and Sources

While chicory root remains the primary source of inulin due to its high concentration, inulin is also extracted from other plant sources such as agave and Jerusalem artichoke. The extraction process involves using hot water to solubilize the fructan, followed by purification steps to obtain inulin in a usable form [22].

Pros of Prebiotic Inulin

Enhanced Digestive Health and Regularity

Prebiotic inulin is recognized for its ability to improve bowel regularity and combat constipation. This dietary fiber is not digested by the human body, allowing it to pass into the colon where it promotes the growth of beneficial bacteria such as Bifidobacteria and Lactobacillus. These bacteria are vital for sustaining a healthy gut microbiome, crucial for efficient digestion and overall gastrointestinal wellness [11][12][18].

Support for Weight Management

Inulin has a low caloric content and can act as a dietary fiber that enhances feelings of fullness, which is beneficial for weight management. Studies have shown that inulin can help reduce body weight and body fat in people with prediabetes by influencing satiety levels and decreasing food intake [13].

Blood Sugar Control

Inulin can positively impact blood sugar control by slowing glucose absorption. This property makes it particularly beneficial for individuals with diabetes. It has been shown to improve glycemic control, and its inclusion in the diet can help manage postprandial blood sugar levels [23].

Improved Mineral Absorption and Bone Health

Inulin enhances the absorption of minerals such as calcium and magnesium, which are crucial for bone health. Clinical studies have demonstrated that inulin increases the bioavailability of these minerals, leading to improved bone density and overall bone health [18].

Cons of Prebiotic Inulin

Gastrointestinal Discomfort

Clinical studies have shown that inulin, a type of dietary fiber, can cause gastrointestinal discomfort such as bloating, flatulence, and diarrhea, particularly when consumed in large amounts. This is attributed to the fact that inulin is a fermentable fiber that the human digestive system cannot fully break down. The fermentation process in the colon produces gases, which can lead to these symptoms [26][27].

Exacerbation of IBS Symptoms

For individuals with irritable bowel syndrome (IBS), inulin can exacerbate symptoms. A study evaluating the efficacy of inulin in patients with IBS with constipation noted that while some patients experienced relief, others saw an aggravation of symptoms such as abdominal pain and bloating [25]. This suggests that inulin’s effects can vary significantly among individuals with sensitive digestive systems.

Potential for Gut Microbiota Imbalance

Although inulin is known for its prebiotic benefits—stimulating the growth of beneficial gut bacteria—excessive or unmoderated consumption can lead to an imbalance in gut microbiota. This imbalance can potentially lead to more digestive health issues. The study on the effects of prebiotic therapy on the gastrointestinal microbiome highlighted the complexity of microbial responses to inulin, indicating that outcomes can vary depending on individual gut microbiota compositions [24].

Recent Development of Prebiotic Inulin

Digestive Health and Microbiota

Clinical trials have demonstrated that inulin-type fructans significantly impact gut health by promoting the growth of beneficial bacteria such as Bifidobacterium and Lactobacillus. These effects contribute to improved bowel regularity and immune function. A systematic review confirmed the prebiotic potential of inulin, noting its ability to enhance intestinal microbiota composition and support various intestinal and extraintestinal processes [29].

Mental Health Benefits

Emerging research suggests that inulin may also have mental health benefits due to its interaction with the gut-brain axis. A study on the effects of prebiotic and probiotic supplementation in patients with fibromyalgia syndrome indicated that inulin could improve sleep quality, although its impact on pain and psychological distress was less pronounced compared to probiotics [30].

Obesity and Metabolic Health

Inulin’s role in obesity and metabolic health has been critically reviewed, with findings suggesting that it can influence hepatic lipid metabolism and thereby assist in managing obesity-related conditions like nonalcoholic fatty liver disease. The effectiveness of inulin in these applications may vary based on individual differences in gut microbiota composition prior to dietary intervention [28].

What are the differences between Prebiotics Human Milk Oligosaccharide (HMO) and Prebiotic Inulin?

Prebiotics Human Milk Oligosaccharide (HMO) and Prebiotic Inulin differ significantly in their structure, source, and function, which impacts their role in human health. HMOs are complex sugars naturally found in human breast milk. They are composed of a diverse array of structures, with over 200 different HMOs identified, each having unique functional properties.

HMOs are not digested by the infant but serve as a selective growth substrate for beneficial gut bacteria, particularly Bifidobacteria. They also play a critical role in immune development and have been shown to inhibit the binding of pathogens to host tissues, thereby providing a protective effect against infections.

In contrast, Inulin is a type of fructan and is found in a variety of plants, including chicory root, onions, and garlic. It is a linear chain of fructose units terminated by a glucose unit. Inulin is also not digested in the upper gastrointestinal tract and thus serves as a food source for beneficial gut bacteria. It predominantly stimulates the growth of Bifidobacteria and Lactobacilli, contributing to improved bowel regularity, better gut health, and enhanced immune function.

What happens when both of these two Prebiotics Human Milk Oligosaccharide (HMO) and Prebiotic Inulin together with both Probiotic Bifidobacterium Longum and and Probiotic Bifidobacterium Breve are combined in a health dietary supplement?

When both HMO and Inulin are combined with probiotics such as Bifidobacterium longum and Bifidobacterium breve in a dietary supplement, the synergistic effects can be quite beneficial for gut health. The presence of both prebiotics provides a broader spectrum of substrates for these beneficial bacteria, potentially leading to a more significant increase in their growth and activity. This can enhance the colonization resistance against pathogens, improve the gut barrier function, and support a more balanced immune response.

Bifidobacterium longum and Bifidobacterium breve are among the first microbes to colonize the human gut and are considered important for maintaining a healthy microbiota. They can metabolize both HMO and Inulin, producing short-chain fatty acids (SCFAs) like acetate, propionate, and butyrate, which serve as energy sources for colonocytes and have anti-inflammatory properties.

The combination of these prebiotics and probiotics in a supplement can thus support a more robust and diverse microbial community in the gut, which is linked to various health benefits, including enhanced digestion and absorption of nutrients, improved metabolic functions, and a reduced risk of gastrointestinal disorders and infections. However, the specific outcomes can vary depending on the individual’s existing gut microbiota composition, diet, and overall health.

References:

[1] Bajic, Danica, et al. “HMOs Exert Marked Bifidogenic Effects on Children’s Gut Microbiota Ex Vivo, Due to Age-Related Bifidobacterium Species Composition.” Nutrients, vol. 15, no. 7, 30 Mar. 2023, p. 1701, doi:10.3390/nu15071701, www.ncbi.nlm.nih.gov/pmc/articles/PMC10097135/. Accessed 21 Apr. 2024.

[2] Schönknecht, Yannik Bernd, et al. “Clinical Studies on the Supplementation of Manufactured Human Milk Oligosaccharides: A Systematic Review.” Nutrients, vol. 15, no. 16, 17 Aug. 2023, p. 3622, doi:10.3390/nu15163622, www.ncbi.nlm.nih.gov/pmc/articles/PMC10458772/. Accessed 21 Apr. 2024.

[3] Hu, Miaomiao, Mengli Li, Chenchen Li, Ming Miao, and Tao Zhang. “Effects of Human Milk Oligosaccharides in Infant Health Based on Gut Microbiota Alteration.” Journal of Agricultural and Food Chemistry, vol. 71, no. 2, 5 Jan. 2023, pp. 994-1001. PubMed, doi:10.1021/acs.jafc.2c05734. https://pubmed.ncbi.nlm.nih.gov/36602115/. Accessed 21 Apr. 2024.

[4] Sanz Morales, Patricia, et al. “The Potential Role of Human Milk Oligosaccharides in Irritable Bowel Syndrome.” Microorganisms, vol. 10, no. 12, 25 Nov. 2022, Art. no. 2338. doi:10.3390/microorganisms10122338. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781515/. Accessed 21 Apr. 2024.

[5] Yu, Hai and Xi Chen. “CHAPTER 11. Enzymatic and Chemoenzymatic Synthesis of Human Milk Oligosaccharides (HMOS).” Synthetic Glycomes (2019): n. pag. https://www.semanticscholar.org/paper/4e0213ca1ccb1919e95162057e299008ddd6e504. Accessed 21 Apr. 2024.

[6] Hill, David R., Jo May Chow, and Rachael H. Buck. “Multifunctional Benefits of Prevalent HMOs: Implications for Infant Health.” PubMed Central, 2021. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539508/. Accessed 21 Apr. 2024.

[7] Fibbiani, Martina, Leonardo Ghelli Luserna Di Rorà, Tommaso Novelli, and Diego G. Peroni. “The Impact of Human Milk Oligosaccharides on Health from Infancy to Childhood.” Minerva Pediatr (Torino), vol. 74, no. 6, Dec. 2022, pp. 724-732. PubMed, doi:10.23736/S2724-5276.22.07037-9. https://pubmed.ncbi.nlm.nih.gov/36178339/. Accessed 21 Apr. 2024.

[8] Adams, C., and B. Gutiérrez. “The Benefits of Human Milk Oligosaccharides in Adult Nutrition.” Semantic Scholar, 2018. https://www.semanticscholar.org/paper/cdc217f54165ebd43148259bf807b67bff07e5fa. Accessed 21 Apr. 2024.

[9] Sato, Yohei, et al. “Sialyllactose Enhances the Short-Chain Fatty Acid Production and Barrier Function of Gut Epithelial Cells via Nonbifidogenic Modification of the Fecal Microbiome in Human Adults.” Microorganisms, vol. 12, no. 2, 25 Jan. 2024, Art. no. 252. doi:10.3390/microorganisms12020252. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10892346/. Accessed 21 Apr. 2024.

[10] Ellingson, David J., et al. “Analysis of Six Human Milk Oligosaccharides (HMO) in Infant Formula and Adult Nutritionals by 2AB Labeling and Quantification with HILIC-FLD: First Action 2022.02.” J AOAC Int, vol. 106, no. 1, 22 Dec. 2022, pp. 112-126. doi:10.1093/jaoacint/qsac112. https://pubmed.ncbi.nlm.nih.gov/36106998/. Accessed 21 Apr. 2024.

[11] Meyer, D., and M. Stasse-Wolthuis. “The Bifidogenic Effect of Inulin and Oligofructose and Its Consequences for Gut Health.” Eur J Clin Nutr, vol. 63, no. 11, Nov. 2009, pp. 1277-1289. doi:10.1038/ejcn.2009.64. https://pubmed.ncbi.nlm.nih.gov/19690573/. Accessed 21 Apr. 2024.

[12] Roberfroid, M B. “Prebiotics: Preferential Substrates for Specific Germs?” Am J Clin Nutr, vol. 73, no. 2 Suppl, Feb. 2001, pp. 406S-409S. doi:10.1093/ajcn/73.2.406s. https://pubmed.ncbi.nlm.nih.gov/11157349/. Accessed 21 Apr. 2024.

[13] Guess, Nicola D., Anne Dornhorst, Nick Oliver, Jimmy D. Bell, E. Louise Thomas, and Gary S. Frost. “A Randomized Controlled Trial: The Effect of Inulin on Weight Management and Ectopic Fat in Subjects with Prediabetes.” Nutr Metab (Lond), vol. 12, 2015. PubMed Central, doi:10.1186/s12986-015-0033-2. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619305/. Accessed 21 Apr. 2024.

[14] Dehghan, Parvin, Bahram Pourghassem Gargari, Mohammad Asghari Jafar-Abadi, and Akbar Aliasgharzadeh. “Inulin Controls Inflammation and Metabolic Endotoxemia in Women with Type 2 Diabetes Mellitus: A Randomized-Controlled Clinical Trial.” Int J Food Sci Nutr, vol. 65, no. 1, Feb. 2014, pp. 117-23. doi:10.3109/09637486.2013.836738. https://pubmed.ncbi.nlm.nih.gov/24059649/. Accessed 21 Apr. 2024.

[15] Lightowler, Helen, Sangeetha Thondre, Anja Holz, and Stephan Theis. “Replacement of Glycaemic Carbohydrates by Inulin-Type Fructans from Chicory (Oligofructose, Inulin) Reduces the Postprandial Blood Glucose and Insulin Response to Foods: Report of Two Double-Blind, Randomized, Controlled Trials.” Eur J Nutr, vol. 57, no. 3, Apr. 2018, pp. 1259-1268. doi:10.1007/s00394-017-1409-z. https://pubmed.ncbi.nlm.nih.gov/28255654/. Accessed 21 Apr. 2024.

[16] Cai, Xiaxia, et al. “Milk Powder Co-Supplemented with Inulin and Resistant Dextrin Improves Glycemic Control and Insulin Resistance in Elderly Type 2 Diabetes Mellitus: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial.” Mol Nutr Food Res, vol. 62, no. 24, Dec. 2018, doi:10.1002/mnfr.201800865. https://pubmed.ncbi.nlm.nih.gov/30346655/. Accessed 21 Apr. 2024.

[17] Jeridi, Dalel, et al. “The Safety of Long-Term Proton Pump Inhibitor Use on Cardiovascular Health: A Meta-Analysis.” J Clin Med, 2022. PubMed Central, doi:10.3390/jcm11144096. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322047/. Accessed 21 Apr. 2024.

[18] Hughes, Riley L., et al. “The Prebiotic Potential of Inulin-Type Fructans: A Systematic Review.” Advances in Nutrition, vol. 13, no. 2, Mar. 2022, pp. 492–529. PubMed Central, doi:10.1093/advances/nmab119. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8970830/. Accessed 21 Apr. 2024.

[19] Rodriguez, Julie, et al. “Physical Activity Enhances the Improvement of Body Mass Index and Metabolism by Inulin: A Multicenter Randomized Placebo-Controlled Trial Performed in Obese Individuals.” BMC Medicine, vol. 20, 2022. PubMed Central, doi:10.1186/s12916-022-02299-z. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966292/. Accessed 21 Apr. 2024.

[20] Yang, Yongde, et al. “Prebiotics for Depression: How Does the Gut Microbiota Play a Role?” Frontiers in Nutrition, 2023. PubMed Central, doi:10.3389/fnut.2023.1206468. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10358272/. Accessed 21 Apr. 2024.

[21] Nagy, Dávid U., et al. “Effect of Chicory-Derived Inulin-Type Fructans on Abundance of Bifidobacterium and on Bowel Function: A Systematic Review with Meta-Analyses.” Crit Rev Food Sci Nutr, vol. 63, no. 33, 2023, pp. 12018-12035. doi:10.1080/10408398.2022.2098246. https://pubmed.ncbi.nlm.nih.gov/35833477/. Accessed 21 Apr. 2024.

[22] Rastall, R. A. “Functional Oligosaccharides: Application and Manufacture.” Annu Rev Food Sci Technol, 2010, pp. 305-39. doi:10.1146/annurev.food.080708.100746. https://pubmed.ncbi.nlm.nih.gov/22129339/. Accessed 21 Apr. 2024.

[23] Kordowski, Anna, et al. “PalatinoseTM (Isomaltulose) and Prebiotic Inulin-Type Fructans Have Beneficial Effects on Glycemic Response and Gut Microbiota Composition in Healthy Volunteers—A Real-Life, Retrospective Study of a Cohort That Participated in a Digital Nutrition Program.” Frontiers in Nutrition, vol. 9, 7 Mar. 2022, Art. no. 829933. doi:10.3389/fnut.2022.829933. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948463/. Accessed 21 Apr. 2024.

[24] Ribeiro, M. C., Ylas Levi, V. Moraschini, M. R. Messora, and F. A. C. Furlaneto. “Effects of Prebiotic Therapy on Gastrointestinal Microbiome of Individuals with Different Inflammatory Conditions: A Systematic Review of Randomized Controlled Trials.” Probiotics Antimicrob Proteins, vol. 16, no. 2, Apr. 2024, pp. 673-695. doi:10.1007/s12602-023-10075-5. https://pubmed.ncbi.nlm.nih.gov/37093515/. Accessed 21 Apr. 2024.

[25] Dorofeev, A., S. Tkach, Y. Z. Gurkalo, and others. “Evaluation of the Efficacy of Inulin Application in Patients with Irritable Bowel Syndrome with Constipation.” Modern Gastroenterology, 30 Apr. 2023. Semantic Scholar, doi:10.30978/mg-2023-2-51. https://www.semanticscholar.org/paper/95ee09ff110aed54de6713a066d7a54eaa3cb429. Accessed 21 Apr. 2024. 

[26] Wilson, Bridgette, and Kevin Whelan. “Prebiotic Inulin-Type Fructans and Galacto-Oligosaccharides: Definition, Specificity, Function, and Application in Gastrointestinal Disorders.” J Gastroenterol Hepatol, vol. 32, Suppl 1, Mar. 2017, pp. 64-68. doi:10.1111/jgh.13700. https://pubmed.ncbi.nlm.nih.gov/28244671/. Accessed 21 Apr. 2024.

[27] Bărboi, Oana-Bogdana, et al. “Effect of Inulin in the Treatment of Irritable Bowel Syndrome with Constipation (Review).” Exp Ther Med, vol. 20, no. 6, Dec. 2020, p. 185. doi:10.3892/etm.2020.9315. https://pubmed.ncbi.nlm.nih.gov/33101475/. Accessed 21 Apr. 2024.

[28] Hu, Yaolian, et al. “Prebiotic Inulin as a Treatment of Obesity Related Nonalcoholic Fatty Liver Disease Through Gut Microbiota: A Critical Review.” Crit Rev Food Sci Nutr, vol. 63, no. 7, 2023, pp. 862-872. doi:10.1080/10408398.2021.1955654. https://pubmed.ncbi.nlm.nih.gov/34292103/. Accessed 21 Apr. 2024.

[29] Hughes, Riley L., David A. Alvarado, Kelly S. Swanson, and Hannah D. Holscher. “The Prebiotic Potential of Inulin-Type Fructans: A Systematic Review.” Advances in Nutrition, vol. 13, no. 2, Mar. 2022, pp. 492–529. PubMed Central, doi:10.1093/advances/nmab119. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8970830/. Accessed 21 Apr. 2024.

[30] Patients with Fibromyalgia Syndrome: A Double-Blind, Placebo-Controlled Randomized Clinical Trial.” Psychol Health Med, vol. 29, no. 3, Mar. 2024, pp. 528-541. doi:10.1080/13548506.2023.2216464. https://pubmed.ncbi.nlm.nih.gov/37224267/. Accessed 21 Apr. 2024.